Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
Dec 15, 2022
Management Tracks
Debra Yu leaving LianBio
Plus: Bayer vet Weinand appointed chair at Umoja, and updates from vTv, Gradalis, Generate and more
Read More
BioCentury
|
Dec 19, 2019
Combined inhibition of EIF4A1 and glutaminase for pancreatic cancer
Read More
BioCentury
|
Jul 29, 2017
Finance
Potentiator potential
Why Pfizer Venture Investments led Effector's $38.6M series C
Read More
BioCentury
|
Jul 24, 2017
Financial News
Effector raises $38.6M in series C
Read More
BioCentury
|
Sep 18, 2014
Distillery Therapeutics
Indication: Cancer
Read More
BioCentury
|
Dec 1, 2011
Distillery Therapeutics
Indication: Infectious disease
Read More
BioCentury
|
Sep 15, 2011
Distillery Therapeutics
Indication: Cancer
Read More
Items per page:
10
1 - 7 of 7